Advertisement

The Scientist

» FDA and microbiology

Most Recent

image: A Placebo for Schizophrenia?

A Placebo for Schizophrenia?

By | June 26, 2012

The placebo effect in clinical trials of the mental disorder has increased over the past decade.

1 Comment

image: Nanoparticles Prevent Disease

Nanoparticles Prevent Disease

By | June 22, 2012

Medical devices coated with selenium nanoparticles reduce the growth of a deadly hospital-borne infection.

1 Comment

image: Roundup from Microbiology Meeting

Roundup from Microbiology Meeting

By | June 21, 2012

Some of the interesting stories researchers were discussing at this year’s American Society of Microbiology meeting in San Francisco.

0 Comments

image: A Plea to the FDA

A Plea to the FDA

By | June 21, 2012

Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.

2 Comments

image: New FDA Review Process Debated

New FDA Review Process Debated

By | June 20, 2012

Industry experts discuss the agency’s plans to make the drug approval process more transparent.

0 Comments

image: The Ecology of Fear

The Ecology of Fear

By | June 15, 2012

Grasshoppers in fear of predation die with less nitrogen in their bodies than unstressed grasshoppers, which can affect soil ecology.

2 Comments

image: @Pharma Branching Out

@Pharma Branching Out

By | June 11, 2012

More than half of pharmaceutical companies on Twitter use more than one handle.

0 Comments

image: The Fungus Among Us

The Fungus Among Us

By | June 11, 2012

Researchers find a slew of new fungal species inhabiting the human gut, and suggest a link to an inflammatory bowel disease.

1 Comment

image: Oil Spill Changes Microbe Communities

Oil Spill Changes Microbe Communities

By | June 8, 2012

The beaches around the Gulf of Mexico harbor different nematodes, protists and fungi now than they did before the Deepwater Horizon disaster in April 2010.

2 Comments

image: FDA OKs Early Stage Trials

FDA OKs Early Stage Trials

By | June 5, 2012

The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.

1 Comment

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
Ingenuity Systems
Ingenuity Systems

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement